At the 2025 TEDCO Expo, ABL, Inc. Chief Scientific Officer Timothy Fouts discussed how the company, a contract development and manufacturing organization for viral-based...
The Delaware and Cambridge-based TechBio company will use the federal award to replace trial-and-error bioprocess development with intelligent computational modeling — targeting one of...
Catalent has been hit by another round of workforce reductions at its Maryland operations, marking the latest chapter in an ongoing contraction affecting the...
November 6, 2025 | BioBuzz Staff Report
Catalent has confirmed a new round of layoffs at its Baltimore operations, marking the company’s second workforce reduction...
Philadelphia, October 7, 2025 — GEMMABio, a leading genetic medicines company founded by gene therapy pioneer Dr. James M. Wilson, has launched Rare Therapeutics,...
The Association for the Advancement of Blood & Biotherapies (AABB) has released its first edition of Cell and Gene Therapy Standards for Pharmacy, a...
Dr. Vinay Prasad, the FDA’s Chief Medical and Scientific Officer and head of the Center for Biologics Evaluation and Research (CBER), resigned abruptly on July 29
